Prof Sir Chris Evans
17 May 2021
Prof Sir Chris Evans OBE is a successful and internationally renowned scientific entrepreneur. He has launched, financed and built more than 40 life sciences companies from their inception, now valued at $7 billion. Twenty companies were listed on stock exchanges around the world during a career spanning 35 years. Sir Chris has returned $billions in cash to investors. Notable companies include Ellipses Pharma, Excalibur Healthcare Services, Chiroscience, Celsis, BioVex, ReNeuron, Vectura, Piramed and Merlin Biosciences Ltd.
Appointed OBE in 1995 for services to medical bioscience, he was then knighted in 2001 for services to bioscience and enterprise. He has advised four UK Prime Ministers on pharmaceutical, life sciences and healthcare policy as well as overseas governments including Algeria, Libya, Malta, Qatar and the United Arab Emirates.
He holds several academic chairs, fellowships and 12 honorary doctorates in science at some 16 British universities and he has been the author of more than 100 scientific publications and patents.
Sir Chris has raised more than $3billion of investment for research projects, developing 85 innovative medical products. Sir Chris has always had a strong focus on cancer research and clinical development of new cancer medicines and has raised more than $1billion for cancer research projects.
More information will follow.
Back to all Events